Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Prospective Study of Strategies to Combine Pre-Exposure Prophylaxis (PrEP)With Prevention Efforts

NCT01832571 is registered in ClinicalTrials.gov with FHI 360 as lead sponsor.

NCT NCT01832571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01832571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Prospective Study of Strategies to Combine Pre-Exposure Prophylaxis (PrEP)With Prevention Efforts
Lead sponsor
FHI 360
Phase
Not applicable
Overall status
Withdrawn
Start date
June 30, 2013
Completion date
July 31, 2013
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv